Skip to content
Lower risk Drug recall · FDA · Published September 26, 2025

Dr. Reddy's Succinylcholine Chloride Injection Recall: Stability Testing Issue

Dr. Reddy's recalls 25 vials of Succinylcholine Chloride Injection due to decreased preservative concentration found during stability testing. This may affect medication safety.

🇺🇸 FDA recall #D-0008-2026DrugDr. Reddy's ›
Take action

Contact the company

Recalling firmDr. Reddy's Laboratories, Inc.600 College Rd E Ste 4000 · Princeton, NJ 08540-6636
✎ GovInfoNow plain-language explainer

Dr. Reddy's is recalling 25 vials of Succinylcholine Chloride Injection because stability testing showed decreased preservative concentration. This could affect medication safety for patients using the product. Read more at govinfonow.com/recall/31768-dr-reddy-s-succinylcholine-chloride-injection-recall-stability-testing-issue.

Source Summary by GovInfoNow · govinfonow.com/recall/31768-dr-reddy-s-succinylcholine-chloride-injection-recall-stability-testing-issue · Updated August 18, 2026 · FDA enforcement record: FDA #D-0008-2026

Cite this page

“Dr. Reddy's Succinylcholine Chloride Injection Recall: Stability Testing Issue.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/31768-dr-reddy-s-succinylcholine-chloride-injection-recall-stability-testing-issue. Based on FDA recall #D-0008-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0008-2026%22&limit=1).

The Food and Drug Administration announced on Sept. 26, 2025, that Dr. Reddy's Laboratories Inc. voluntarily recalled Succinylcholine Chloride Injection due to out-of-specification stability testing results indicating decreased preservative concentration.

How to tell if you have it

  • Brand: Dr. Reddy's
  • Product: Succinylcholine Chloride Injection, USP, 200 mg/10 mL (20 mg/mL), 25 x 10 mL Multiple-Dose Vials
  • NDC: 43598-666-25
  • Lot #: K250048

The hazard

The recall addresses out-of-specification results during six-month stability testing that revealed a decreased preservative concentration in the drug product.

Context

GovInfoNow's records show Dr. Reddy's Laboratories, Inc. has 85 other recalls on record since April 9, 2012. Recent brand recalls include a Nov. 11, 2025, Varenicline Tablets recall for subpotent drug risk and a June 30, 2025, Omeprazole Capsules recall for foreign tablets found. Other recent recalls of similar products include Blaine Labs TERPENICOL Antifungal Solution Recall (April 8, 2026), Somerset Therapeutics Cisatracurium Besylate Injection Recall (Nov. 26, 2025), and Safecor Health Fluphenazine Elixir Recall (Aug. 13, 2026).

How to tell if you have this one

Look for vials labeled 'Succinylcholine Chloride Injection, USP, 200 mg/10 mL (20 mg/mL), 25 x 10 mL Multiple-Dose Vials' with NDC code 43598-666-25 and lot number K250048.

  • Brand
    Dr. Reddy's
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Verify the product label includes NDC 43598-666-25 and lot number K250048.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide within the USA.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 19 days after the firm started it.

1. Firm started the recall: Sep 26, 202512. FDA classified it Class II: Oct 7, 202523. Published in FDA’s Enforcement Report: Oct 15, 202532025
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Dr. Reddy's recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0008-2026 (September 26, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0008-2026 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA